Global Nasogastric Tube Market was valued at USD 305.8 million in 2017 and is expected to reach USD 473.9 million by 2024, at a constant CAGR of 6.4%.

Factors driving the growth of the market are; growing demand from nutritional support to children and adult patients and increasing number of hospitalized pediatric and geriatric patients. Moreover, increasing number of premature baby births and growing number of neck and facial surgeries is further propelling the market growth.

The years used for the assessment are as follows;

Historical year: 2014, 2015, and 2016

Base year: 2017

Forecast period: 2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total nasogastric tube market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global nasogastric tube market
Finalizing the overall size and share of the global nasogastric tube market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the nasogastric tube market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the nasogastric tube market and provide their competitive landscape

MARKET SCOPE

The research scope for nasogastric tube market is as follows:

By Product Type
Levin Tube
Sengstaken-Blakemore Tube
Other

By Application
Children Use
Adult Use

By End-use
Hospitals
Clinics

By Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)

FREE ANALYSIS

Nutrition plays an important role in maintaining health, as well as in prevention a various diseases. The nasogastric (NG) tubes are used for infant, children, and geriatric patients who are not able to intake medicine or nutrition orally. Premature and sick babies have a limited supply of energy and nutrients. The NG tubes deliver the nutrients and medicinal support in these emergency cases. The tube is inserted through patient’s nose into the patient’s stomach. Moreover, the NG tube may be inserted while the patients are in the operating room, ICU or regular hospital ward.

The key factors driving the growth of the market are; growing demand for nutritional support to children and adult patients and increasing number of hospitalized pediatric and geriatric patients. Moreover, growing number of premature baby births and increasing number of neck and facial surgeries is further propelling the market growth.

Geographically, Europe held the largest share of the global market in 2017. The growth in the region is attributed to the increasing number of patients suffering from chronic diseases and small bowel obstruction. Approximately, 10 million NG tubes are used annually in the Europe, of which 1 million tubes are used in the United Kingdom alone. North America held the second largest share of the global market. About 1.2 million NG tubes are placed every year in the U.S., due to increasing number of hospitalized pediatric and geriatric patients. Moreover, adoption of new intubation techniques for nasogastric tubes is further propelling the marker growth in this region.

Some of the key companies operating in the market include Bard Medical, Inc., Cardinal Health, Inc., GBUK Enteral Ltd, B. Braun Melsungen AG, Bicakcilar AS, Andersen Products, Inc., Guangdong Baihe Medical Technology Co., Ltd., Degania Silicone Ltd., and among others.